Cas:667436-66-0 5-chloro-2-[(2-chloro-4-fluorophenyl)methoxy]benzaldehyde manufacturer & supplier

Chemical Name:5-chloro-2-[(2-chloro-4-fluorophenyl)methoxy]benzaldehyde

CAS.NO:667436-66-0

Synonyms:5-chloro-2-[(2-chloro-4-fluorophenyl)methoxy]benzaldehyde

Molecular Formula:C₁₄H₉Cl₂FO₂

Molecular Weight:299.12400

HS Code:2913000090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:411.4ºC at 760 mmHg

Density:1.398g/cm3

Index of Refraction:1.607

PSA:26.30000

Exact Mass:297.99600

LogP:4.52400

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-chloro-2-[(2-chloro-4-fluorophenyl)methoxy]benzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-chloro-2-[(2-chloro-4-fluorophenyl)methoxy]benzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-chloro-2-[(2-chloro-4-fluorophenyl)methoxy]benzaldehyde Use and application,5-chloro-2-[(2-chloro-4-fluorophenyl)methoxy]benzaldehyde technical grade,usp/ep/jp grade.

Related News: A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. 5-chloro-2-[(2-chloro-4-fluorophenyl)methoxy]benzaldehyde manufacturer During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. 5-chloro-2-[(2-chloro-4-fluorophenyl)methoxy]benzaldehyde supplier A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. 5-chloro-2-[(2-chloro-4-fluorophenyl)methoxy]benzaldehyde vendor Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. 5-chloro-2-[(2-chloro-4-fluorophenyl)methoxy]benzaldehyde factory During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology.